retatrutide vietnam Retatrutide, Triple-Agonist GLP-1 Research Peptide Retatrutide | GLP-1R/GIPR/GCGR ligand |
Description
If you are losing weight and tolerating the medication well at 1 mg, there is no clinical reason to increase further
About Obesity
95% CI, 0.44 to 1.12
One long-standing theory is that the mechanical effects of excessive abdominal fat elevate intra-abdominal pressure, which increases intrathoracic pressure and, thereby, increases cerebral venous pressure, and, consequently ICP (13)
doi: 10.1210/jcem.80.12.8530635
